Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Editor’s Picks: Gold Price Breaks US$3,700 for First... September 20, 2025 Successful Due Diligence Ends – $20M Placement To... August 25, 2025 SAGA Metals Announces Closing of Fully Subscribed Non-Brokered... October 11, 2025 Sarama Resources Completes Mt Venn Gold Project Acquisition July 23, 2025 Sarama Files Memorial in US$242M Damages Claim Against... November 3, 2025 Standard Uranium Retains 100% Unencumbered Ownership of the... December 12, 2025 Skyharbour Consolidates 100% Interest in the Russell Lake... November 17, 2025 Rising US-Venezuela Tensions,CPC Shutdown Push Oil Prices Higher December 3, 2025 Editor’s Picks: ECB Issues Gold Warning, Uranium Stocks... May 24, 2025 Issue of Shares and Cleansing Notice June 27, 2025